Yong Li

Peripheral blood markers predictive of outcome and immune-related adverse events in advanced non-small cell lung cancer treated with PD-1 inhibitors

Lihong Peng, Yong Wang, Fen Liu et al. · Cancer Immunology Immunotherapy · 2020 · 274 citations · Full text

Medicine, Immunology, Oncology +17

Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial

Bhavana Pothuri, Sileny Han, Dana M. Chase et al. · Gynecologic Oncology · 2024 · 13 citations · Full text

Pharmacy, Oncology, Pharmacology +16

Survival Predictors of Resectable Gallbladder Carcinoma: An Analysis of the Surveillance, Epidemiology, and End Results Database

Jisheng Zhu, Yunxiang Wu, Weidong Xiao et al. · The American Surgeon · 2022 · 12 citations

Medicine, Oncology, Surgery +17

rhG-CSF is associated with an increased risk of metastasis in NSCLC patients following postoperative chemotherapy

Yong Wang, Fang Chen, Renfang Chen et al. · BMC Cancer · 2022 · 10 citations · Full text

Medicine, Oncology, Surgery +14